According to Evofem Biosciences 's latest financial reports the company's current EPS (TTM) is $117.31. In 2022 the company made an earnings per share (EPS) of -$816.14 an increase over its 2021 EPS that were of -$3,078.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $117.31 | -114.37% |
2022 | -$816.14 | -73.49% |
2021 | -$3,078 | -24.7% |
2020 | -$4,087 | -1.36% |
2019 | -$4,144 | -68.52% |
2018 | -$13,162 | -87.41% |
2017 | -$104,587 | 889.01% |
2016 | -$10,575 | -70.06% |
2015 | -$35,325 | 288.02% |
2014 | -$9,104 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -100.23% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -100.85% | ๐บ๐ธ USA |